On June 24, 2025, ZyVersa Therapeutics, Inc. signed an Equity Purchase Agreement, allowing them to sell up to $10 million of their common stock, with a related press release issued on June 25, 2025. This arrangement includes a commitment to register the shares sold within 120 days, contingent on market conditions.